Immunotherapy: Recurrent and/or metastatic head and neck cancer portends a poor prognosis with traditional treatments, but current immunotherapy with immune checkpoint inhibitors has the potential to improve these clinical outcomes. This review focuses on the major breakthroughs that have led to the current understanding of immunotherapy in head and neck cancer as well as the future direction of the field. Ultimately, this understanding will guide clinicians on the selection of patients with head and neck cancer and practical considerations before starting immunotherapy.
http://ift.tt/2uzxiwD
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract The purpose of this study was to evaluate the outcome improvements after total hip arthroplasty (THA) using the Western Ontario an...
-
Abstract Objective The objective of this study was to test the effectiveness of resin-based materials against erosive enamel wear under er...
-
Publication date: Available online 12 November 2016 Source: Nano Today Author(s): Pengfei Zhang, Gang Liu, Xiaoyuan Chen The increasingly...
-
Aim: The authors aimed to research the effects of autologous platelet-rich plasma, which is known for the positive effects on wound healing,...
-
Identification and characterization of antibacterial compound(s) of cockroaches ( Periplaneta americana ) : Abstract Infectious diseases ...
-
Abstract Chronic exposure to high altitude may lead to hyperuricemia. We investigated the prevalence of hyperuricemia and its risk factors...
-
Background and Purpose: Human papilloma virus-related oropharyngeal carcinoma (HPV+ OPC) is a unique entity compared to HPV-unrelated (HPV-)...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου